All News about Veracyte Inc![]()
Earnings Outlook For Veracyte
February 21, 2024
Via Benzinga
![]() ![]()
Veracyte Completes Acquisition of C2i Genomics
February 06, 2024
From Veracyte, Inc.
Via Business Wire
![]() ![]()
Veracyte: Q3 Earnings Insights
November 07, 2023
Via Benzinga
![]() ![]() From Veracyte, Inc.
Via Business Wire
![]() ![]()
The Latest Analyst Ratings for Veracyte
October 20, 2023
Via Benzinga
![]() ![]() ![]() ![]()
Veracyte Announces Third Quarter 2023 Financial Results
November 07, 2023
From Veracyte, Inc.
Via Business Wire
![]() ![]()
Veracyte to Participate in the Stephens Annual Investment Conference
November 02, 2023
From Veracyte, Inc.
Via Business Wire
![]() ![]() ![]() ![]() From Veracyte, Inc.
Via Business Wire
![]() ![]() ![]() ![]() ![]() ![]()
Veracyte Names Phillip G. Febbo, M.D., as Chief Scientific Officer and Chief Medical Officer
September 27, 2023
From Veracyte, Inc.
Via Business Wire
![]() ![]() ![]() ![]()
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|